Standard serum concentrations and normal fluctuations of CEA, CA 50 and CA 242 during twelve months in men and women aged 60â
![Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-81/MediaObjects/12885_2006_Article_433_Fig2_HTML.jpg)
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma | PLOS ONE
![The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-4987-0/MediaObjects/12885_2018_4987_Fig2_HTML.png)
The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text
![Fluctuations in calcitonin. Calcitonin, CEA and RECIST are graphed as a... | Download Scientific Diagram Fluctuations in calcitonin. Calcitonin, CEA and RECIST are graphed as a... | Download Scientific Diagram](https://www.researchgate.net/publication/236911183/figure/fig3/AS:667807037521931@1536229013931/Fluctuations-in-calcitonin-Calcitonin-CEA-and-RECIST-are-graphed-as-a-percent-of.png)
Fluctuations in calcitonin. Calcitonin, CEA and RECIST are graphed as a... | Download Scientific Diagram
![Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients](https://www.spandidos-publications.com/article_images/ol/14/6/ol-14-06-7549-g00.jpg)
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
![Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy - ScienceDirect Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419369261-gr2.jpg)
Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy - ScienceDirect
![The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ] The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2019/7433/1/fig-2-full.png)
The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ]
Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on lon
![Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA | SpringerLink Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10147-019-01597-6/MediaObjects/10147_2019_1597_Fig6_HTML.png)
Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA | SpringerLink
![Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy - ScienceDirect Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419369261-gr3.jpg)
Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy - ScienceDirect
![Fluctuations in calcitonin. Calcitonin, CEA and RECIST are graphed as a... | Download Scientific Diagram Fluctuations in calcitonin. Calcitonin, CEA and RECIST are graphed as a... | Download Scientific Diagram](https://www.researchgate.net/profile/David-Hong-8/publication/236911183/figure/fig3/AS:667807037521931@1536229013931/Fluctuations-in-calcitonin-Calcitonin-CEA-and-RECIST-are-graphed-as-a-percent-of_Q640.jpg)
Fluctuations in calcitonin. Calcitonin, CEA and RECIST are graphed as a... | Download Scientific Diagram
![Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-65720-8/MediaObjects/41598_2020_65720_Fig1_HTML.png)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
A novel method for monitoring high-risk breast cancer with tumor markers: CA 15.3 compared to CEA and TPA
![CEA Fluctuation During a Single Fluorouracil-based Chemotherapy Cycle for Metastatic Colorectal Cancer | Anticancer Research CEA Fluctuation During a Single Fluorouracil-based Chemotherapy Cycle for Metastatic Colorectal Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/33/1/253/F1.large.jpg)
CEA Fluctuation During a Single Fluorouracil-based Chemotherapy Cycle for Metastatic Colorectal Cancer | Anticancer Research
![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-fx1.jpg)
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
![The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-4987-0/MediaObjects/12885_2018_4987_Fig1_HTML.png)
The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text
![The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer—A retrospective cohort study - Tong - 2018 - Cancer Medicine - Wiley Online Library The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer—A retrospective cohort study - Tong - 2018 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/17816739-d87c-4cae-a80c-b7669a08efac/cam41814-fig-0001-m.jpg)
The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer—A retrospective cohort study - Tong - 2018 - Cancer Medicine - Wiley Online Library
![Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-21048-y/MediaObjects/41598_2018_21048_Fig1_HTML.jpg)